Plain-English translation of NCT06982300 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new imaging scan called [68Ga]Ga-DOTA-TOC PET that may help doctors better understand your nasopharyngeal cancer and choose the best treatment for you. The scan looks for specific markers on cancer cells that might predict how well treatment will work. Researchers will take images before and three weeks after you start chemotherapy or radiation, and collect blood samples to track how your body responds.
Currently, doctors don't have a reliable way to predict which patients with nasopharyngeal cancer will respond best to different treatments. This new imaging scan could help personalize treatment plans and improve outcomes for future patients with this type of cancer.
You likely qualify if…
You likely don't qualify if…
You will have two imaging scans — one before treatment begins and another three weeks after starting chemotherapy or radiation. You'll also have blood drawn at several timepoints: before treatment, three weeks in, after chemotherapy finishes (if applicable), and after all radiation is complete. Each scan takes about 25 minutes. The study uses tissue from your original cancer biopsy to examine specific markers in your cancer cells.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Netherlands